Single dose prophylaxis in colorectal surgery

I P Bissett1, W H Isbister

  • 1Department of Surgery, Wellington Clinical School of Medicine.

Insights

Single-dose moxalactam disodium (Latamoxef) prophylaxis in colorectal surgery showed a 13% wound infection rate. This approach is cost-effective with few side effects, justifying its use.

Area of Science:

  • Surgical Infection Prevention
  • Pharmacology
  • Clinical Microbiology

Background:

  • Wound infections are a significant complication in open colorectal surgery.
  • Optimizing antibiotic prophylaxis is crucial for reducing surgical site infections.
  • Previous studies utilized prolonged antibiotic regimens.

Purpose of the Study:

  • To evaluate moxalactam disodium (Latamoxef) as a single-dose prophylactic antibiotic.
  • To assess the efficacy and safety of moxalactam disodium in open colorectal surgery.
  • To determine the wound infection rate associated with single-dose prophylaxis.

Main Methods:

  • A prospective study involving 105 consecutive patients undergoing open colorectal surgery.
  • Moxalactam disodium (1g) administered as a single dose at anesthesia induction.
  • Exclusion criteria included non-administration or alternative antibiotic use.
  • Wound infection rates were monitored for early and late infections.

Main Results:

  • Eleven early and one late wound infection were observed, resulting in a 13% overall infection rate (95% CI 7-19).
  • The observed infection rate was higher than a previous study using prolonged prophylaxis (9.8%), but the difference was not statistically significant due to unmatched patient groups.
  • Moxalactam disodium was associated with a low incidence of side effects.

Conclusions:

  • Single-dose moxalactam disodium (1g) is a cost-effective prophylactic antibiotic for open colorectal surgery.
  • The low side effect profile supports its continued use.
  • Further investigation may be warranted, considering the observed infection rate compared to prolonged prophylaxis.

Related Concept Videos

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Endoscopic Procedures II: Colonoscopy01:25

Endoscopic Procedures II: Colonoscopy

The colon, or large intestine, is the final segment of the digestive system. Its primary functions include absorbing water and vitamins produced by gut bacteria and transforming waste from liquid to solid to form stool. In adults, the large intestine is approximately 5 feet long and consists of four main sections:
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...